Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 2,493,700 | 2,322,900 | 2,045,500 | 1,899,600 | 1,678,600 |
| Cost of Goods | 617,200 | 625,600 | 516,600 | 491,000 | 489,800 |
| Gross Profit | 1,876,500 | 1,697,300 | 1,528,900 | 1,408,600 | 1,188,800 |
| Operating Expenses | 1,234,000 | 1,205,100 | 1,057,000 | 988,700 | 889,500 |
| Operating Income | 642,700 | 492,800 | 472,500 | 419,900 | 300,100 |
| Interest Expense | 17,200 | 17,200 | 9,800 | 4,400 | 3,100 |
| Other Income | -3,100 | 668,400 | 48,500 | -27,300 | -13,400 |
| Pre-tax Income | 622,400 | 1,144,000 | 511,200 | 388,200 | 283,600 |
| Income Tax | 127,500 | 332,900 | 122,100 | 96,700 | 46,900 |
| Net Income Continuous | 494,900 | 811,100 | 389,100 | 291,500 | 236,700 |
| Net Income | $494,900 | $811,100 | $389,100 | $291,500 | $236,700 |
| EPS Basic Total Ops | 0.77 | 1.27 | 0.58 | 0.42 | 0.35 |
| EPS Basic Continuous Ops | 0.77 | 1.27 | 0.58 | 0.42 | 0.34 |
| EPS Diluted Total Ops | 0.75 | 1.25 | 0.57 | 0.41 | 0.33 |
| EPS Diluted Continuous Ops | 0.75 | 1.25 | 0.57 | 0.41 | 0.33 |
| EBITDA(a) | $708,500 | $561,400 | $535,400 | $473,600 | $358,100 |